Insider filing · AXSM
Ari Maizel
Chief Commercial Officer
profile →
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Ari Maizel sold $1.4M of Axsome Therapeutics (AXSM)
Executed Jan 21, disclosed Jan 23, 2 days later.
Value, as filed
$1.4M
7,500 sh × $184.44
Executed
Jan 21
the trade date, as filed
Disclosed
Jan 23
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AMAri Maizel (Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $1.4M of AXSM (7,500 sh × $184.44, as filed), executed Jan 21.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ari Maizel in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$1.4M7,500 sh × $182.42
Exec Apr 22
Filed Apr 23 · 5:30 PM ET